Skip to main content
news
A Midea company sign is seen at the Appliance and Electronics World Expo (AWE) in Shanghai, China March 23, 2021. REUTERS/Aly Song

 

Skadden, Arps, Slate, Meagher & Flom, Jia Yuan Law Offices, and Shihui Partners are advising Chinese home appliance maker Midea Group on its HK$26.97 billion ($3.46 billion) share offering in Hong Kong, the city's largest listing in more than three years.

Freshfields Bruckhaus Deringer and King & Wood Mallesons are representing the joint sponsors and underwriters on the offering.

According to Reuters, the offering by the Shenzhen-listed Midea would be the biggest in Hong Kong since JD Logistics raised $3.16 billion in May 2021. The deal eclipses Hong Kong's most recent biggest deal, by Chinese lithium battery maker CALB, which raised $1.3 billion in October 2022.

The joint sponsors and underwriters include China International Capital Corporation, Merrill Lynch, UBS, CLSA, and Goldman Sachs.

The Skadden team was led by partners Haiping Li, Shu Du, Kai Sun and Yilin Xu.

The Freshfields team was led by China Chairman Teresa Ko, Head of China ECM Richard Wang and partner Howie Farn.

The Jia Yuan team saw the leadership of founding partner Xu Ying and senior partner Liu Xing.

And the KWM team was led by partners Gong Mulong, Su Zheng, and Huang Xiaoxue.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.